生殖系变异破坏微小RNA预测前列腺癌放疗后长期泌尿生殖系统毒性
本研究在两家机构纳入201例接受根治性放疗的前列腺癌患者(108例常规分割放疗,93例立体定向体部放疗),评估生殖系功能性微小RNA靶点单核苷酸多态性(mirSNP)对晚期≥2级泌尿生殖系统毒性的预测价值。基于22个mirSNP的弹性网模型区分常规分割放疗高危(71.5%)与低危(7.5%)患者,AUC为0.76-0.81;基于32个mirSNP的模型区分立体定向体部放疗高危(64.7%)与低危(3.9%)患者,AUC为0.81-0.87,且模型具有治疗方式特异性。
要点
- 常规分割放疗后晚期≥2级泌尿生殖系统毒性粗发生率为16%,立体定向体部放疗后为15%。
- 基于22个mirSNP的弹性网模型预测常规分割放疗毒性高危71.5%对比低危7.5%,AUC为0.76-0.81。
- 基于32个mirSNP的模型预测立体定向体部放疗毒性高危64.7%对比低危3.9%,AUC为0.81-0.87。
核心结论
- 使用生殖系mirSNP的预测模型对常规分割放疗或立体定向体部放疗后晚期≥2级泌尿生殖系统毒性具有高准确度,且模型对每种治疗方式具有特异性,提示晚期放射敏感性的生殖系预测因素具有分割依赖性。
- 需要前瞻性研究进一步验证这些结果。
研究设计与样本
- 研究纳入两家机构接受两种根治性放疗的前列腺癌男性201例,其中108例接受常规分割放疗,93例接受立体定向体部放疗。
- 评估生殖系DNA中功能性mirSNP的存在,开发随机森林、提升树和弹性网模型,以RTOG量表预测晚期≥2级泌尿生殖系统毒性。
主要发现
- 常规分割放疗后晚期≥2级泌尿生殖系统毒性粗发生率为16%,立体定向体部放疗后为15%。
- 基于22个mirSNP的弹性网模型区分常规分割放疗患者毒性高危(71.5%)与低危(7.5%),AUC为0.76-0.81。
- 基于32个mirSNP的弹性网模型区分立体定向体部放疗患者毒性高危(64.7%)与低危(3.9%),AUC为0.81-0.87。
- 这些模型对所接受的治疗类型具有特异性。
局限性
- 需要前瞻性研究进一步验证这些结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The purpose of this study was to determine whether single nucleotide polymorphisms disrupting microRNA targets (mirSNPs) can serve as predictive biomarkers for toxicity after radiotherapy for prostate cancer and whether these may be differentially predictive depending on radiation fractionation. MATERIALS AND METHODS: We identified 201 men treated with two forms of definitive radiotherapy for prostate cancer at two institutions: 108 men received conventionally-fractionated radiotherapy (CF-RT) and 93 received stereotactic body radiotherapy (SBRT). Germline DNA was evaluated for the presence of functional mirSNPs. Random forest, boosted trees and elastic net models were developed to predict late grade ≥2 GU toxicity by the RTOG scale. RESULTS: The crude incidence of late grade ≥2 GU toxicity was 16% after CF-RT and 15% after SBRT. An elastic net model based on 22 mirSNPs differentiated CF-RT patients at high risk (71.5%) versus low risk (7.5%) for toxicity, with an area under the curve (AUC) values of 0.76-0.81. An elastic net model based on 32 mirSNPs differentiated SBRT patients at high risk (64.7%) versus low risk (3.9%) for toxicity, with an area under the curve (AUC) values of 0.81-0.87. These models were specific to treatment type delivered. Prospective studies are warranted to further validate these results. CONCLUSION: Predictive models using germline mirSNPs have high accuracy for predicting late grade ≥2 GU toxicity after either CF-RT or SBRT, and are unique for each treatment, suggesting that germline predictors of late radiation sensitivity are fractionation-dependent. Prospective studies are warranted to further validate these results.
引用
- Kishan AU, Marco N, Schulz-Jaavall MB, et al. Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation. Radiother Oncol. 2022. PMID: 34990726. doi:10.1016/j.radonc.2021.12.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。